Ferroptosis Compound Library

Ferroptosis Compound Library
SKU
MEXHY-L051-50
Packaging Unit
50 μl
Manufacturer
MedChemExpress

Availability: loading...
Price is loading...
Description: Ferroptosis is a novel type of cell death program that is distinct from apoptosis, necroptosis and autophagy. It is dependent on iron and reactive oxygen species (ROS) and is characterized by lipid peroxidation. As a novel type of cell death, ferroptosis has distinct properties and recognizing functions involved in physical conditions or various diseases including cancers, neurodegenerative diseases, acute renal failure, etc.
Ferroptosis is a novel type of cell death program that is distinct from apoptosis, necroptosis and autophagy. It is dependent on iron and reactive oxygen species (ROS) and is characterized by lipid peroxidation. As a novel type of cell death, ferroptosis has distinct properties and recognizing functions involved in physical conditions or various diseases including cancers, neurodegenerative diseases, acute renal failure, etc.
MCE carefully collected a unique collection of 925 ferroptosis signaling pathway related compounds with ferroptosis-inducing or -inhibitory activity. MCE Ferroptosis Compound Library is a useful tool to study ferroptosis mechanism as well as related diseases.
MCE Ferroptosis Compound Library can be supplied as pre-dissolved Solutions or Solid. For pre-dissolved solutions in this library, there are 910 compounds supplied in 10 mM solution, 14 compounds supplied in 2 mM solution and 1 compounds supplied in 3 mg/mL solution.
For pre-dissolved solutions, 10 mM for compounds with the solubility not lower than 10 mM, 2 mM for compounds with solubility between 2 mM and 10 mM, and 3 mg/mL for compounds with unconfirmed molecular weight and solubility not lower than 3 mg/mL.

Advantages:
  • A unique collection of 925 bioactive ferroptosis signal pathway related compounds for high throughput screening (HTS) and high content screening (HCS).
  • Targets include glutathione peroxidase 4, iron, dipeptidylpeptidase 4, lipoxygenase, p53, etc.
  • A useful tool for the research of the regulation of ferroptosis and related diseases.
  • Bioactivity and safety confirmed by preclinical research and clinical trials. Some compounds have been approved by FDA.
  • Structurally diverse, medicinally active, and cell permeable.
  • More detailed compound information with structure, IC50, and brief introduction.
  • NMR and HPLC validated to ensure high purity and quality.
  • All compounds are in stock and continuously updated.


Formulation: A collection of 925 ferroptosis compounds supplied as pre-dissolved Solutions or SolidSolution:910 compounds supplied in 10 mM solution,14 compounds supplied in 2 mM solution,1 compounds supplied in 3 mg/mL solution.

Layout: 96-well storage tube or 96-well plate: 1st and 12th column are left empty.384-well plate: the first two columns and the last two columns are left empty.Compounds with different concentrations or dissolved in different solvents will be put on separate plates.This way of layout may increase the number of plates because there could be three solvents and three concentrations. If you have other requirements, please let us know.

Container: 96- or 384-well Plate with Peelable Foil Seal; 96-well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode
More Information
SKU MEXHY-L051-50
Manufacturer MedChemExpress
Manufacturer SKU HY-L051-50
Green Labware No
Package Unit 50 μl
Quantity Unit STK
Product information (PDF)
×
MSDS (PDF)
×